Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI107102

Slow fractional removal of nonextractable iodine from rat tissue after injection of labeled l-thyroxine and 3,5,3′-triiodo-l-thyronine: A possible clue to the mechanism of initiation and persistence of hormonal action

Jack H. Oppenheimer, Martin I. Surks, and Harold L. Schwartz

1Endocrine Research Laboratory, Department of Medicine, Montefiore Hospital and Medical Center, and the Albert Einstein College of Medicine, Bronx, New York 10467

Find articles by Oppenheimer, J. in: PubMed | Google Scholar

1Endocrine Research Laboratory, Department of Medicine, Montefiore Hospital and Medical Center, and the Albert Einstein College of Medicine, Bronx, New York 10467

Find articles by Surks, M. in: PubMed | Google Scholar

1Endocrine Research Laboratory, Department of Medicine, Montefiore Hospital and Medical Center, and the Albert Einstein College of Medicine, Bronx, New York 10467

Find articles by Schwartz, H. in: PubMed | Google Scholar

Published November 1, 1972 - More info

Published in Volume 51, Issue 11 on November 1, 1972
J Clin Invest. 1972;51(11):2796–2807. https://doi.org/10.1172/JCI107102.
© 1972 The American Society for Clinical Investigation
Published November 1, 1972 - Version history
View PDF
Abstract

Previous studies have shown that a small but significant proportion of radioiodine from labeled L-thyroxine (T4) and 3,5,3′-triiodo-L-thyronine (T3) is incorporated into plasma and tissue proteins and is not, therefore, extractable with ethanol or other organic solvents. Other studies have shown that the complex consists, at least in part, of the iodothyronine in apparent covalent linkage with protein. In the present series of experiments the disappearance rate of nonextractable iodine (NEI) was determined in plasma, liver, and kidney after the injection of rats with a single dose of T4 and T3 labeled with radioiodine in the phenolic ring. The t½ of NEI decay was substantially longer than the t½ of the initial metabolic removal of T4 (16 hr) and T3 (4-6 hr). Thus, between days 3 and 11 the average t½ of plasma NEI derived from T4 was 2.2 days, from T3, 1.9 days; kidney NEI from T4, 7.4 days, from T3, 6.1 days; hepatic NEI from T4, 4.3 days, from T3, 5.2 days.

The slow disappearance of liver NEI was of special interest in connection with an analysis of previously published data by Tata and associates dealing with the sequential tissue effects after the injection of a single dose of T3 into thyroidectomized rats. The t½ of decay of the various biological effects measured, primarily in the liver, appeared similar to each other, averaging between 4 and 6 days. These findings are compatible with the existence of a single long-lived intermediate governing the tissue expression of thyroid hormone. The t½ of hepatic NEI in similarly prepared animals (thyroidectomized and injected with 25 μg of T3) was found to be 4.5 days. The coincidence in the slow fractional disappearance rates of hepatic NEI and the dissipation of hormonal tissue effects raises the distinct possibility that T3 interacts with specific cellular receptor sites to form covalent complexes which are slowly removed and serve both to initiate and to perpetuate hormonal action. A mathematical analysis of hormonal reaction mechanisms, based on the assumption of a linearly responsive system, a t½ of T3 of 4 hr, and a t½ of 4.5 days for the postulated long-lived “messenger” suggests that maximal expression of hormonal activity cannot be attained before 20 hr after the injection of a hormone pulse. This value is broadly consonant with the observed data accumulated by Tata and associates. The existence of a long-lived messenger, possibly a species of NEI, would therefore explain not only the slow dissipation of hormonal effects but also the well-recognized “lag-time” in the expression of hormonal action.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2796
page 2796
icon of scanned page 2797
page 2797
icon of scanned page 2798
page 2798
icon of scanned page 2799
page 2799
icon of scanned page 2800
page 2800
icon of scanned page 2801
page 2801
icon of scanned page 2802
page 2802
icon of scanned page 2803
page 2803
icon of scanned page 2804
page 2804
icon of scanned page 2805
page 2805
icon of scanned page 2806
page 2806
icon of scanned page 2807
page 2807
Version history
  • Version 1 (November 1, 1972): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts